Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Accepted on 30 May 2025

Intracerebroventricular Calycosin Attenuates Cerebral Ischemia-Reperfusion Injury in Rats via HMGB1-Dependent Pyroptosis Inhibition

in Inflammation Pharmacology

Yuhui Zhang
Qiguang Wu
Yanjin Pan
Min Xin
Wenbo Wang
Xiaoya Zhai
Peiquan Zhou
Chong Zhang
Yong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596087

Original Research

Published on 30 May 2025

Biodegradable sustained-release microneedle patch loaded with clindamycin hydrochloride: a breakthrough in acne management

in Inflammation Pharmacology

Haomei Fan
Ruohan Liao
Yiling Yang
Yan Xing
Chengdong Zhang
Xuwei Luo
Chao Pu
Liling Wu
Xingping Li
Juhua Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1575635

202 views

Review

Published on 30 May 2025

Blockade of IL-1 family cytokines in the treatment of rheumatoid arthritis

in Inflammation Pharmacology

Kexin Wang
Haoge Luo
Liping Liu
Hang Gao
Yanyan Song
Dong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577628

170 views

Original Research

Published on 30 May 2025

Determination of nine prostaglandins in the arachidonic acid metabolic pathway with UHPLC-QQQ-MS/MS and application to in vitro and in vivo inflammation models

in Inflammation Pharmacology

Yufeng Huang
Mengxian Wang
Ziqi Yang
Xiaotong Wang
Xinxin Wang
Fan He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1595059

131 views

Review

Accepted on 29 May 2025

Salt Sensitivity and Myocardial Fibrosis: Unraveling the Silent

in Inflammation Pharmacology

Katongo Hope Mutengo
Owen Ngalamika
Annet Kirabo
Sepiso Kenias Masenga

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1626492

Systematic Review

Accepted on 28 May 2025

Comparative effectiveness and safety of tofacitinib vs adalimumab in patients with rheumatoid arthritis: a systematic review and meta-analysis

in Inflammation Pharmacology

Chunyan Zhu
Yibo Zheng
Zilu Wang
Guozong Chen
Yushi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1524214

148 views

Mini Review

Accepted on 28 May 2025

Cytokine Release Syndrome and CAR T Cell Therapy: Modulating the Intensity of the Inflammatory Response and Resolution within the Tumor Microenvironment

in Inflammation Pharmacology

David F Driscoll
Bruce R Bistrian

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1615526

102 views

Systematic Review

Accepted on 26 May 2025

Effects of dupilumab on quality of life in patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Yunqing Sun
Haibo Liu
Yingjun Gao
Hong Sang
Qingtao Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1587977

220 views

Review

Published on 23 May 2025

Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol

in Inflammation Pharmacology

Bei-Bei Xiong
Yu-Mei Zhuo
Huan Wang
Qiao-Ling Zheng
Feng Tang
Qun Huang
Man Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598022

300 views

Original Research

Accepted on 19 May 2025

-1 -AduCPI2 alleviates MSU-induced acute gouty arthritis in mice by inhibiting cathepsin S and the C5a-C5aR1 axis

in Inflammation Pharmacology

Sijing Liu
Yongli SITU
Zheng Shao
Li DENG
Meng Liang
Bin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1604329

113 views

Review

Published on 19 May 2025

The key players of inflammasomes and pyroptosis in sepsis-induced pathogenesis and organ dysfunction

in Inflammation Pharmacology

Lujian Zhu
Minli Hu
Haoming Xu
Hanglu Xu
Binbin Ren
Ruiyan Xu
Maodong Guo
Haijun Chen
Dehe Zhang
Hao Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586364

408 views

Review

Published on 19 May 2025

Immunopharmacology of gastric cancer–deciphering immune cell subset responses and nanoparticle-mediated targeting

in Inflammation Pharmacology

Yanting Wang
Ning Ding
Lina Qi
Wenwen Chen
Panyisha Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611234

347 views

Editorial

Published on 16 May 2025

Editorial: Inflammation and lipid signaling in disease pathogenesis

in Inflammation Pharmacology

Paola Patrignani
Bernhard Brüne
Angelo Sala
Pietro Minuz
Dieter Steinhilber

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1623707

334 views

Original Research

Published on 14 May 2025

Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata

in Inflammation Pharmacology

Luning Li
Zhen Sun
Wenxue Sun
Yujuan Zhai
Na Ding
Wei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507348

1,005 views

Original Research

Published on 14 May 2025

The green tea component (−)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells

in Inflammation Pharmacology

Rita Rosenthal
Anne Waesch
Kopano Valerie Masete
Alain S. Massarani
Jörg-Dieter Schulzke
Nina A. Hering

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559812

536 views

Correction

Published on 13 May 2025

Corrigendum: C16 peptide promotes vascular growth and reduces inflammation in a neuromyelitis optica model

in Inflammation Pharmacology

Haohao Chen
Xiaoxiao Fu
Jinzhan Jiang
Shu Han

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611115

306 views